Learn More
KRISHGEN BIOSYSTEMS Immunoassay for the estimation of Rituximab (RITUXAN) in serum and plasma. Calibrated against WHO standard 14/210 from NIBSC. Assay Range: 10 - 640 ng/ml; Sensitivity: 9.4 ng/ml.
Supplier: KRISHGEN BIOSYSTEMS KBI1010
Pack Size: 1 x 96 wells. Background: Rituximab is a monoclonal antibody which has high specificity for CD20 and it is used to treat certain autoimmune diseases and types of cancer. It is also used for non-Hodgkins lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein - Barr virus-positive mucocutaneous ulcers. This mAb-based Rituximab ELISA is validated against ICH M10 guidelines for bioassays. It is optimised for use with human samples. If you would like to use animal samples, please contact us. ELISA Features include a pre-coated plate with break-apart wells, standardisation and Precision CV <10%.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.